The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05774951
Brief Title: A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy (CAMBRIA-1)

First Submitted : February 16, 2023
First Submitted that Met QC Criteria : March 7, 2023
First Posted : March 20, 2023

Last Update Submitted that Met QC Criteria : June 19, 2024
Last Update Posted : June 21, 2024 (Estimate)